Skip to main content
Cancer Explained
Donate

NewsResearch

The Family Smoking Prevention and Tobacco Control Act

A dated cancer milestone (2009): gave the FDA authority to regulate tobacco products. Why it mattered, its limits, and how the field evolved.

By Cancer Explained Editorial TeamPublished Updated

Original commentary from the Cancer Explained editorial team.

A hand sets a lighter down on a wooden table beside a stoneware mug
Setting It Down — illustrative photograph, not of anyone named in this story.

Historical context: this page explains an event dated 2009. It was published as an explainer on July 12, 2026 and is not breaking news.

Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.

Historical milestone — this page describes an event dated 2009. It is not current breaking news.

The agency that could not touch tobacco

For most of the twentieth century the FDA regulated food, drugs, devices and cosmetics. Cigarettes sat outside all of it.

The Family Smoking Prevention and Tobacco Control Act changed that. Signed into law on June 22, 2009, it gave the FDA authority over the manufacture, distribution and marketing of tobacco products.

Note what that authority is not. It is not a ban, and it is not a health warning campaign. It is product regulation, applied to a product that kills people when used as intended.

What the law stopped

The FDA groups the youth-focused provisions together. The law bans:

  • Sales to people under a set minimum age.
  • Vending machine sales, except in places where under-age people are never present or admitted.
  • Packages of fewer than 20 cigarettes.
  • Tobacco-brand sponsorship of sports, entertainment, social or cultural events.
  • Free giveaways of sample cigarettes and brand-name promotional items.

The small-pack ban is subtler than it looks. Cheap four-cigarette packs are how a habit starts on pocket money.

Words the law puts on a package

The act requires larger, more visible warnings on smokeless tobacco. Smokeless tobacco means moist snuff, chewing tobacco and snus.

Every package and advertisement must carry one of four statements: that the product can cause mouth cancer; that it can cause gum disease and tooth loss; that it is not a safe alternative to cigarettes; or that smokeless tobacco is addictive.

The sizing is specified. On packages, the warning goes on the two principal sides and covers at least 30 percent of each. In advertisements it covers at least 20 percent of the ad.

The end of "light" and "mild"

Before 2009, packs marketed as light, low or mild implied reduced harm without having to prove it.

The law bars those claims unless a company files a modified risk tobacco product application and obtains an FDA order permitting the claim. The burden shifted from the reader to the manufacturer.

Companies must also give the FDA detailed information about the ingredients in their products.

Flavors, and the exception everyone argued about

The act bans cigarettes with characterizing flavors, with two exceptions: menthol and tobacco.

Menthol was not an oversight. It was a negotiated carve-out, and it has been contested ever since. The FDA retains authority to set product standards, including regulating nicotine and ingredient levels.

Manufacturers must register annually and open their facilities to FDA inspection every two years. The whole regulatory operation is funded by user fees on manufacturers, assessed by US market share.

Four things the law forbids the FDA to do

The limits are as deliberate as the powers. The FDA cannot:

  • Require prescriptions to buy tobacco products.
  • Require nicotine yields to be reduced to zero.
  • Ban face-to-face sales in a particular category of retail outlet.
  • Ban entire classes of tobacco product.

So the agency can regulate nicotine downward but not to zero, and can restrict how cigarettes are sold but cannot remove them from shops.

The age limit, then and now

The 2009 text drew its own line here. It barred the FDA from setting a minimum sale age above 18. Section 104 instead ordered a study on the public health implications of raising it, with a report to Congress within five years.

The FDA's current overview says the minimum age is 21. That change came from later legislation, not from this act. It is a useful reminder that a 2009 statute is not the law as it stands.

When to get checked

Two cancers sit behind these provisions, and they have different warning signs.

For lung cancer, the screening criteria are numeric. The US Preventive Services Task Force recommends annual low-dose CT for adults aged 50 to 80 with a 20 pack-year smoking history who smoke now or quit within the past 15 years. NCI notes low-dose CT is the only test shown to reduce lung cancer deaths; chest x-ray and sputum cytology do not. Our page on lung cancer screening covers eligibility in detail.

For mouth and throat cancer, there is no population screening program, so symptoms carry the load. A mouth ulcer or white or red patch that has not healed in three weeks, a lump in the neck, persistent hoarseness, pain on swallowing, or a loose tooth with no dental cause all warrant an appointment. Our page on head and neck cancer symptoms goes through each.

The scale on both sides

The American Cancer Society projects 229,410 new US lung and bronchus cancer cases and 124,990 deaths for 2026, and SEER reprints both. Lung cancer causes 20 percent of all US cancer deaths, more than any other type. Five-year relative survival for 2016 to 2022 cases is 29.5 percent, and only 24 percent are found while still confined to the lung.

For oral cavity and pharynx cancer, the Society's 2026 projection is 60,480 new cases and 13,150 deaths. Five-year relative survival, measured by SEER on 2016 to 2022 cases, is 69.9 percent overall: 88.7 percent for localized disease, 69.7 percent with regional spread, and 36.0 percent when distant. Median age at diagnosis is 65.

Both sets are registry averages across whole populations. They describe groups, not people, and they mix every cause and every treatment era together. Our page on smoking, vaping and lung cancer risk covers what changes an individual's odds.

What this does and doesn't change

It gave a regulator jurisdiction. It did not make tobacco safe, or unavailable.

It is federal law, and it explicitly preserves state, local and tribal authority to regulate tobacco in specific respects. Local rules can be stricter.

The 2009 text has been amended since, most visibly on the minimum age. Anyone relying on the detail should read the current law rather than the original act.

And regulation is a population tool. It does not diagnose anyone, and it does not decide whether a particular person should be screened. That is a clinic conversation.

Sources

How this article was prepared

An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.

The National Cancer Information Foundation publishes Cancer Explained. This page is for learning. It is not medical advice and does not suggest a test or treatment.

See an error, old source, or unclear wording? Tell us

Know someone who needs this?

Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.

Email itText itWhatsApp

Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.

Put the story in context

Prevention, possible warning signs, screening, and diagnosis

This story relates to Lung cancer. The information below is general: it does not reveal anything else about a public person’s health, and not every point applies to every cancer. Personal advice depends on age, symptoms, family history, exposures, and medical history.

  • Prevention and risk reduction

    Not every cancer can be prevented. Avoiding tobacco, protecting skin from ultraviolet radiation, limiting alcohol, staying active, and receiving recommended HPV or hepatitis B vaccination can lower the risk of certain cancers. A risk factor is not a prediction or a cause in one individual.

    NCI prevention information

  • Symptoms and possible early signs

    Possible signs vary and are often caused by conditions other than cancer. Changes worth discussing include a new lump, unexplained bleeding or weight loss, a persistent cough, lasting bowel or bladder changes, a changing skin spot, or symptoms that persist or worsen. Some early cancers cause no symptoms.

    NCI signs and symptoms

  • Screening and early detection

    Screening looks for certain cancers before symptoms begin. Recommended tests exist only for some cancers and depend on age and risk. Screening can have benefits and harms; it is not the same as evaluating a new symptom, and there is no single routine scan or blood test that reliably screens for every cancer.

    NCI cancer screening information

  • How cancer is diagnosed

    Diagnosis may involve a history and exam, imaging, laboratory tests, and often a biopsy. Pathology can identify the cancer type and may test biomarkers that guide treatment. Symptoms, screening results, tumor markers, or online stories alone cannot confirm cancer.

    NCI diagnosis information

Learn about this story’s cancer topic

A public story may encourage questions, but it should not be used to estimate your risk or choose testing. Contact a healthcare professional about a persistent or concerning change. Seek urgent care for severe or rapidly worsening symptoms.

Go deeper with NCI